Acrospire Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,497
Closed -$68K 2652
2017
Q1
$68K Buy
7,497
+2,800
+60% +$29.2K 0.06% 657
2016
Q4
$51K Buy
4,697
+1,500
+47% +$20K 0.02% 1392
2016
Q3
$52K Sell
3,197
-2,700
-46% -$38K 0.03% 1048
2016
Q2
$56K Buy
5,897
+2,224
+61% +$24.2K 0.04% 974
2016
Q1
$52K Buy
+3,673
New +$38K 0.04% 919

Other funds holding NPTN

Acrospire Investment Management's NPTN Position: Q2 2017 in Review

Acrospire Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2017, closing a stake of 7,497 shares — an estimated $68K sold.

Acrospire Investment Management first reported a position in NPTN in Q1 2016 and held it in 5 quarters. The position peaked at $68K in Q1 2017. 101 funds tracked by Wall St. Rank hold NPTN as of Q2 2017.

  • Acrospire Investment Management reported no remaining NEOPHOTONICS CORP position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 7,497 NEOPHOTONICS CORP shares in Q2 2017, an estimated $68K.
  • Acrospire Investment Management first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's NEOPHOTONICS CORP position peaked at $68K in Q1 2017.
  • 101 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.